Neurobiological and psychopathological variables related to emotional instability: A study of their capability to discriminate patients with bulimia nervosa from healthy controls

Neuropsychobiology

Volumn 63, Issue 4, 2011, Pages 242-251

  Vaz Leal, Francisco J ^a,b   Rodríguez Santos, Laura ^a   García Herráiz, M Angustias ^a,b   Ramos Fuentes, M Isabel ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b Extremadura Health Service (SES)   (Spain)

Author keywords

Borderline personality disorder; Bulimia nervosa; Cortisol; Depression; Dopamine; Hypothalamic pituitary adrenal axis; Impulsivity; Serotonin

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; ANALGESIC AGENT; BENZODIAZEPINE; DEXAMETHASONE; DOPAMINE; HOMOVANILLIC ACID; HYDROCORTISONE; MONOAMINE; NORADRENALIN; SEROTONIN;

ADULT; ARTICLE; BORDERLINE STATE; BULIMIA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DOPAMINE URINE LEVEL; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMPULSIVENESS; MAJOR CLINICAL STUDY; MENTAL DISEASE; MENTAL INSTABILITY; NEUROBIOLOGY; NORADRENALIN URINE LEVEL; PRIORITY JOURNAL; SELF DEFEATING PERSONALITY; URINARY EXCRETION;

ADOLESCENT; ADULT; BIOGENIC MONOAMINES; BIOLOGICAL MARKERS; BULIMIA NERVOSA; DEPRESSION; DEXAMETHASONE; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMPULSIVE BEHAVIOR; PERSONALITY DISORDERS; PERSONALITY INVENTORY; PITUITARY-ADRENAL FUNCTION TESTS; PITUITARY-ADRENAL SYSTEM; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; WAKEFULNESS;

EID: 79953884595     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000323445     Document Type: Article

References (79)

1. Van Hanswijck de Jonge P, Van Furth EF, Lacey JH, Waller G: The prevalence of DSMIV personality pathology among individuals with bulimia nervosa, binge eating disorder and obesity. Psychol Med 2003; 33: 1311-1317. (Pubitemid 37265218)
2. Koskela AK, Keski-Rahkonen A, Sihvola E, Kauppinen T, Kaprio J, Ahonen A, Rissanen A: Serotonin transporter binding of [ 123 I] ADAM in bulimic women, their healthy twin sisters, and healthy women: a SPET study. BMC Psychiatry 2007; 7: 19.
3. Lopez C, Tchanturia K, Stahl D, Treasure J: Weak central coherence in eating disorders: a step towards looking for an endophenotype of eating disorders. J Clin Exp Neuropsychol 2009; 31: 117-125.
4. Perugi G, Akiskal HS: The soft bipolar spectrum redefined: focus on the cyclothymic, anxious-sensitive, impulse-dyscontrol, and binge-eating connection in bipolar II and related conditions. Psychiatr Clin North Am 2002; 25: 713-737. (Pubitemid 35351203)
5. Shroff H, Reba L, Thornton LM, Tozzi F, Klump KL, Berrettini WH, Brandt H, Crawford S, Crow S, Fichter MM, Goldman D, Halmi KA, Johnson C, Kaplan AS, Keel P, LaVia M, Mitchell J, Rotondo A, Strober M, Treasure J, Woodside DB, Kaye WH, Bulik CM: Features associated with excessive exercise in women with eating disorders. Int J Eat Disord 2006; 39: 454-461. (Pubitemid 44232262)
6. Steiger H, Gauvin L, Joober R, Israel M, Ng Ying Kin NM, Bruce KR, Richardson J, Young SN, Hakim J: Intrafamilial correspondences on platelet [ 3 H-]paroxetinebinding indices in bulimic probands and their unaffected first-degree relatives. Neuropsychopharmacology 2006; 31: 1785-1792. (Pubitemid 44106710)
7. Wilksch SM, Wade TD: An investigation of temperament endophenotype candidates for early emergence of the core cognitive component of eating disorders. Psychol Med 2009; 39: 811-821.
8. Gleaves DH, Williamson DA, Barker SE: Confirmatory factor analysis of a multidimensional model of bulimia nervosa. J Abnorm Psychol 1993; 102: 173-176. (Pubitemid 23089575)
9. Gleaves DH, Eberenz KP: Validating a multidimensional model of the psychopathology of bulimia nervosa. J Clin Psychol 1995; 51: 181-189.
10. Vaz Leal FJ, Peñas Lledó EM, Guisado Macías JA, Ramos Fuentes MI, López-Ibor Aliño JJ: Psicopatología de la bulimia nerviosa: Un modelo multidimensional. Actas Esp Psiquiatr 2001; 29: 374-379. (Pubitemid 33673993)
11. Vaz Leal FJ, Rodríguez Santos L, García Herráiz MA, Ramos Fuentes MI: Biological correlates of impulsivity and borderline personality symptoms in patients with bulimia nervosa. World Psychiatry 2009; 8: 229.
12. Vaz Leal FJ, Rodríguez Santos L, Ramos Fuentes MI, Cardoso Moreno MJ, Fernández Sanchez N: Neurobiological and clinical predictors of impulsivity in bulimia nervosa. Eur Psychiatry 2009; 24: 381.
13. Cassin SE, von Ranson KM: Personality and eating disorders: a decade in review. Clin Psychol Rev 2005; 25: 895-916. (Pubitemid 41338778)
14. Dawe S, Loxton NJ: The role of impulsivity in the development of substance use and eating disorders. Neurosci Biobehav Rev 2004; 28: 343-351. (Pubitemid 38844381)
15. Diaz-Marsá M, Carrasco JL, Saiz J: A study of temperament and personality in anorexia and bulimia nervosa. J Personal Disord 2000; 14: 352-359. (Pubitemid 32060723)
16. Lejoyeux M, Arbaretaz M, McLoughlin M, Ades J: Impulse control disorders and depression. J Nerv Ment Dis 2002; 190: 310-314. (Pubitemid 34533662)
17. Rowe SL, Jordan J, McIntosh VV, Carter FA, Bulik CM, Joyce PR: Impact of borderline personality disorder on bulimia nervosa. Aust N Z J Psychiatry 2008; 42: 1021-1029.
18. Steiger H, Lehoux PM, Gauvin L: Impulsivity, dietary control and the urge to binge in bulimic syndromes. Int J Eat Disord 1999; 26: 261-274. (Pubitemid 29411693)
19. Torres Pérez I, del Río Sanchez C, Borda Mas M: MCMI-II borderline personality disorder in anorexia and bulimia nervosa. Psicothema 2008; 20: 138-143.
20. Vervaet M, van Heeringen C, Audenaert K: Personality-related characteristics in restricting versus binging and purging eating disordered patients. Compr Psychiatry 2004; 45: 37-43. (Pubitemid 38029973)
21. Chida Y, Hamer M: Chronic psychosocial factors and acute physiological responses to laboratory-induced stress in healthy populations: a quantitative review of 30 years of investigations. Psychol Bull 2008; 134: 829-885.
22. Cunningham-Bussel AC, Root JC, Butler T, Tuescher O, Pan H, Epstein J, Weisholtz DS, Pavony M, Silverman ME, Goldstein MS, Altemus M, Cloitre M, Ledoux J, McEwen B, Stern E, Silbersweig D: Diurnal cortisol amplitude and fronto-limbic activity in response to stressful stimuli. Psychoneuroendocrinology 2009; 34: 694-704.
23. George SA, Khan S, Briggs H, Abelson JL: CRH-stimulated cortisol release and food intake in healthy, non-obese adults. Psychoneuroendocrinology 2010; 35: 607-612.
24. Ozsoy S, Esel E: Hypothalamic-pituitary-adrenal axis activity, dehydroepiandrosterone sulphate and their relationships with aggression in early and late alcohol withdrawal. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 340-347. (Pubitemid 351178947)
25. Scher A, Hall WA, Zaidman-Zait A, Weinberg J: Sleep quality, cortisol levels, and behavioral regulation in toddlers. Dev Psychobiol 2010; 52: 44-53.
26. Tyrka AR, Mello AF, Mello MF, Gagne GG, Grover KE, Anderson GM, Price LH, Carpenter LL: Temperament and hypothalamicpituitary- adrenal axis function in healthy adults. Psychoneuroendocrinology 2006; 31: 1036-1045. (Pubitemid 44485354)
27. Tyrka AR, Wier LM, Anderson GM, Wilkinson CW, Price LH, Carpenter LL: Temperament and response to the Trier Social Stress Test. Acta Psychiatr Scand 2007; 115: 395-402. (Pubitemid 46570064)
28. Beitchman JH, Baldassarra L, Mik H, De Luca V, King N, Bender D, Ehtesham S, Kennedy JL: Serotonin transporter polymorphisms and persistent, pervasive childhood aggression. Am J Psychiatry 2006; 163: 1103-1105. (Pubitemid 44464500)
29. Cleare AJ, Bond AJ: Does central serotonergic function correlate inversely with aggression? A study using D -fenfluramine in healthy subjects. Psychiatry Res 1997; 69: 89-95. (Pubitemid 27147931)
30. Cleare AJ, Bond AJ: Ipsapirone challenge in aggressive men shows an inverse correlation between 5-HT1A receptor function and aggression. Psychopharmacology (Berl) 2000; 148: 344-349. (Pubitemid 30169750)
31. Gonda X, Fountoulakis KN, Juhasz G, Rihmer Z, Lazary J, Laszik A, Akiskal HS, Bagdy G: Association of the s allele of the 5-HTTLPR with neuroticism-related traits and temperaments in a psychiatrically healthy population. Eur Arch Psychiatry Clin Neurosci 2009; 259: 106-113.
32. Netter P, Hennig J, Rohrmann S: Psychobiological differences between the aggression and psychoticism dimension. Pharmacopsychiatry 1999; 32: 5-12. (Pubitemid 29077259)
33. Soloff PH, Lynch KG, Moss HB: Serotonin, impulsivity, and alcohol use disorders in the older adolescent: a psychobiological study. Alcohol Clin Exp Res 2000; 24: 1609-1619.
34. Alia-Klein N, Goldstein RZ, Kriplani A, Logan J, Tomasi D, Williams B, Telang F, Shumay E, Biegon A, Craig IW, Henn F, Wang GJ, Volkow ND, Fowler JS: Brain monoamine oxidase a activity predicts trait aggression. J Neurosci 2008; 28: 5099-5104.
35. Oquendo MA, Mann JJ: The biology of impulsivity and suicidality. Psychiatr Clin North Am 2000; 23: 11-25. (Pubitemid 30140469)
36. Hess C, Reif A, Strobel A, Boreatti-Hummer A, Heine M, Lesch KP, Jacob CP: A functional dopamine-beta-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders. J Neural Transm 2009; 116: 121-130.
37. Kavoussi R, Armstead P, Coccaro E: The neurobiology of impulsive aggression. Psychiatr Clin North Am 1997; 20: 395-403. (Pubitemid 27265724)
38. Birketvedt GS, Drivenes E, Agledahl I, Sundsfjord J, Olstad R, Florholmen JR: Bulimia nervosa - a primary defect in the hypothalamic- pituitary-adrenal axis? Appetite 2006; 46: 164-167. (Pubitemid 43343425)
39. Walsh BT, Roose SP, Katz JL, Dyrenfurth I, Wright L, Vande Wiele R, Glassman AH: Hypothalamic-pituitary-adrenal-cortical activity in anorexia nervosa and bulimia. Psychoneuroendocrinology 1987; 12: 131-140. (Pubitemid 17091458)
40. Bailer UF, Price JC, Meltzer CC, Mathis CA, Frank GK, Weissfeld L, McConaha CW, Henry SE, Brooks-Achenbach S, Barbarich NC, Kaye WH: Altered 5-HT(2A) receptor binding after recovery from bulimia-type anorexia nervosa: relationships to harm avoidance and drive for thinness. Neuropsychopharmacology 2004; 29: 1143-1155. (Pubitemid 38670051)
41. Kaye WH, Frank GK, Meltzer CC, Price JC, McConaha CW, Crossan PJ, Klump KL, Rhodes L: Altered serotonin 2A receptor activity in women who have recovered from bulimia nervosa. Am J Psychiatry 2001; 158: 1152-1155. (Pubitemid 32623123)
42. Kaye WH, Frank GK, Bailer UF, Henry SE, Meltzer CC, Price JC, Mathis CA, Wagner A: Serotonin alterations in anorexia and bulimia nervosa: new insights from imaging studies. Physiol Behav 2005; 85: 73-81. (Pubitemid 40744978)
43. Kaye WH, Bailer UF, Frank GK, Wagner A, Henry SE: Brain imaging of serotonin after recovery from anorexia and bulimia nervosa. Physiol Behav 2005; 86: 15-17. (Pubitemid 41316603)
44. Bailer UF, Kaye WH: A review of neuropeptide and neuroendocrine dysregulation in anorexia and bulimia nervosa. Curr Drug Targets CNS Neurol Disord 2003; 2: 53-59.
45. Brambilla F: Aetiopathogenesis and pathophysiology of bulimia nervosa: biological bases and implications for treatment. CNS Drugs 2001; 15: 119-136. (Pubitemid 32195106)
46. Kaye WH, Ballenger JC, Lydiard RB, Stuart GW, Laraia MT, O'Neil P, Fossey MD, Stevens V, Lesser S, Hsu G: CSF monoamine levels in normal-weight bulimia: evidence for abnormal noradrenergic activity. Am J Psychiatry 1990; 147: 225-229. (Pubitemid 20060481)
47. Koo-Loeb JH, Pedersen C, Girdler SS: Blunted cardiovascular and catecholamine stress reactivity in women with bulimia nervosa. Psychiatry Res 1998; 80: 13-27. (Pubitemid 28370836)
48. Brambilla F, Bellodi L, Arancio C, Ronchi P, Limonta D: Central dopaminergic function in anorexia and bulimia nervosa: a psychoneuroendocrine approach. Psychoneuroendocrinology 2001; 26: 393-409. (Pubitemid 32222944)
49. Takimoto Y, Inui A, Kumano H, Kuboki T: Orexigenic/anorexigenic signals in bulimia nervosa. Curr Mol Med 2003; 3: 349-360. (Pubitemid 36621792)
50. Kutlesic V, Williamson DA, Donald A, Gleaves DH, Barbin JM, Murphy-Eberenz KP: The Interview for the Diagnosis of Eating Disorders-IV: application to DSM-IV diagnostic criteria. Psychol Assess 1998; 10: 41-48. (Pubitemid 28183789)
51. Henderson M, Freeman CPL: A self-rating scale for bulimia: the BITE'. Br J Psychiatry 1987; 150: 18-24.
52. Beck AT: Beck Depression Inventory. Philadelphia, Center for Cognitive Therapy, 1978.
53. Peñas-Lledó EM, Vaz FJ, Ramos I, Waller G: Impulsive behaviours in bulimic patients: relation to general psychopathology. Int J Eat Disord 2002; 32: 98-102.
54. Millon T: Millon Clinical Multiaxial Inventory. II. Minneapolis, National Computers Systems, 1987.
55. Zanarini MC, Frankenburg FR, Vujanovic AA: The interrater and test-retest reliability of the revised diagnostic interview for borderlines (DIB-R). J Personal Disord 2002; 16: 270-276. (Pubitemid 34734446)
56. Steiger H, Young SN, Kin NM, Koerner N, Israel M, Lageix P, Paris J: Implications of impulsive and affective symptoms for serotonin function in bulimia nervosa. Psychol Med 2001; 31: 85-95. (Pubitemid 32046739)
57. Verkes RJ, Pijl H, Meinders AE, Van Kempen GM: Borderline personality, impulsiveness, and platelet monoamine measures in bulimia nervosa and recurrent suicidal behavior. Biol Psychiatry 1996; 40: 173-180. (Pubitemid 26349109)
58. Bushnell JA, Wells JE, Oakley-Browne MA: Impulsivity in disordered eating, affective disorder and substance use disorder. Br J Psychiatry 1996; 169: 329-333.
59. Steiger H, Israel M, Gauvin L, Ng Ying Kin NM, Young SN: Implications of compulsive and impulsive traits for serotonin status in women with bulimia nervosa. Psychiatry Res 2003; 120: 219-229. (Pubitemid 38366049)
60. Wolfe BE, Metzger ED, Levine JM, Finkelstein DM, Cooper TB, Jimerson DC: Serotonin function following remission from bulimia nervosa. Neuropsychopharmacology 2000; 22: 257-263. (Pubitemid 30089536)
61. Kaye WH, Gendall KA, Fernstrom MH, Fernstrom JD, McConaha CW, Weltzin TE: Effects of acute tryptophan depletion on mood in bulimia nervosa. Biol Psychiatry 2000; 47: 151-157. (Pubitemid 30069739)
62. Steiger H, Koerner N, Engelberg MJ, Israel M, Ng Ying Kin NM, Young SN: Self-destructiveness and serotonin function in bulimia nervosa. Psychiatry Res 2001; 103: 15-26. (Pubitemid 32709997)
63. Carrasco JL, Diaz-Marsá M, Hollander E, César J, Saiz-Ruiz J: Decreased platelet monoamine oxidase activity in female bulimia nervosa. Eur Neuropsychopharmacol 2000; 10: 113-117. (Pubitemid 30120040)
64. Monteleone P, Santonastaso P, Pannuto M, Favaro A, Caregaro L, Castaldo E, Zanetti T, Maj M: Enhanced serum cholesterol and triglyceride levels in bulimia nervosa: relationships to psychiatric comorbidity, psychopathology and hormonal variables. Psychiatry Res 2005; 134: 267-273. (Pubitemid 40693944)
65. Wonderlich SA, Crosby RD, Engel SG, Mitchell JE, Smyth J, Miltenberger R: Personality- based clusters in bulimia nervosa: differences in clinical variables and ecological momentary assessment. J Pers Disord 2007; 21: 340-357. (Pubitemid 46911580)
66. Jimerson DC, Wolfe BE, Metzger ED, Finkelstein DM, Cooper TB, Levine JM: Decreased serotonin function in bulimia nervosa. Arch Gen Psychiatry 1997; 54: 529-534. (Pubitemid 27258550)
67. Kaye WH, Greeno CG, Moss H, Fernstrom J, Fernstrom M, Lilenfeld LR, Weltzin TE, Mann JJ: Alterations in serotonin activity and psychiatric symptoms after recovery from bulimia nervosa. Arch Gen Psychiatry 1998; 55: 927-935. (Pubitemid 28465783)
68. Steiger H, Gauvin L, Israel M, Kin NM, Young SN, Roussin J: Serotonin function, personality-trait variations, and childhood abuse in women with bulimia-spectrum eating disorders. J Clin Psychiatry 2004; 65: 830-837.
69. Weltzin TE, Fernstrom MH, Kaye WH: Serotonin and bulimia nervosa. Nutr Rev 1994; 52: 399-408.
70. Coccaro EF: Biological and treatment correlates; in Livesley WJ (ed): Handbook of Personality Disorders. New York, Guilford, 2001, pp 124-135.
71. Gwirtsman HE, Roy-Byrne P, Yager J, Gerner RH: Neuroendocrine abnormalities in bulimia. Am J Psychiatry 1983; 140: 559-563. (Pubitemid 13080523)
72. Hudson JI, Pope HG Jr, Jonas JM, Laffer PS, Hudson MS, Melby JC: Hypothalamic-pituitary- adrenal-axis hyperactivity in bulimia. Psychiatry Res 1983; 8: 111-117.
73. Lindy DC, Walsh BT, Roose SP, Gladis M, Glassman AH: The dexamethasone suppression test in bulimia. Am J Psychiatry 1985; 142: 1375-1376. (Pubitemid 16216585)
74. Bohus M, Schmahl C, Lieb K: New developments in the neurobiology of borderline personality disorder. Curr Psychiatry Rep 2004; 6: 43-50. (Pubitemid 38899251)
75. Gollan JK, Lee R, Coccaro EF: Developmental psychopathology and neurobiology of aggression. Dev Psychopathol 2005; 17: 1151-1171. (Pubitemid 43362208)
76. Pally R: The neurobiology of borderline personality disorder: the synergy of nature and nurture'. J Psychiatr Pract 2002; 8: 133-142.
77. Oades RD: Dopamine may be 'hyper' with respect to noradrenaline metabolism, but 'hypo' with respect to serotonin metabolism in children with attention-deficit hyperactivity disorder. Behav Brain Res 2002; 130: 97-102. (Pubitemid 34195326)
78. Oades RD: Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD). Prog Brain Res 2008; 172: 543-565.
79. Pliszka SR, McCracken JT, Maas JW: Catecholamines in attention-deficit hyperactivity disorder: current perspectives. J Am Acad Child Adolesc Psychiatry 1996; 35: 264-272.(Pubitemid 26072283)